Skip to main content

Veradigm Inc.

corporate_fare Company Profile

Veradigm Inc.

MDRX·OTC·Technology·CIK 0001124804

Veradigm Inc. is a healthcare technology and analytics company that serves the Provider, Payer, and Life Science sectors of healthcare. The company offers software, data, insights, and AI-enhanced solutions designed to improve health outcomes and reduce costs. Its comprehensive solutions include electronic health records (EHR), financial management, population health management, de-identified data, and patient communication solutions. These solutions are built on open integrated platforms, allowing users to streamline workflows, utilize functionality from other software vendors, and exchange data. Veradigm provides a combination of information technology (IT) and point-of-care clinical and financial solutions, emphasizing open interoperability and services to help healthcare organizations achieve clinical, financial, and operational results. Veradigm has a diverse healthcare provider footprint, with its solutions and services used in physician practices, health plans, hospitals, life science companies, laboratory centers, retail pharmacies, radiology centers, pharmacy benefit management companies, urgent care facilities, pharmaceutical manufacturers, health IT companies, insurance companies, Medicare Accountable Care Organizations, media agencies, EHR vendors, third-party aggregators, federal and state governments, academic institutions, payers, and ambulatory facilities. The company's assets, including EHRs, practice management systems, and patient communication platforms, are integrated into its offerings. Through its healthcare provider base and collaborations, Veradigm's addressable markets extend to life science and health plan organizations, providing access to de-identified patient data, provider connectivity, and analytics. Its healthcare provider solutions form the core of its offerings, providing cloud-based and hosted EHR platforms, practice management, revenue cycle services, and patient engagement tools for practices of all sizes and specialties.

Veradigm Inc. (OTC:MDRX) is a publicly traded company in the Technology sector. Wiseek has independently scored 3 items for MDRX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-05-26, rated 8/10. Across its 3 most recent items scored 7 or higher, the top rating is 8/10, with 2 rated 8 or above. Recent SEC coverage for MDRX spans 8-K.

Recent high-impact activity:

  • Veradigm Files Overdue 10-Ks, Reports $291.6M Net Loss on Declining Revenue
  • Veradigm Releases Preliminary 2024/2025 Financials, Reports Significant Debt Reduction Amidst Compliance Efforts
  • Veradigm Extends Stockholder Rights Plan to December 2026 Amidst Relisting Efforts

Financial Snapshot

Fiscal year ended December 31, 2024
Revenue
$594.41M
Net Income
-$291.54M
Diluted EPS
-$2.70
Op. Cash Flow
-$20.02M
Free Cash Flow
-$21.58M
Gross Profit
$302.25M
Operating Income
-$194.66M
Cash & Equivalents
$294.25M
Total Debt
$226.94M
Debt / Equity
0.28×
Net Margin
-49.0%
Shares Outstanding
108.17M sh
Source: 10-K · filed 2026-05-26 · accession 0001193125-26-239413

Short Interest & Short Volume

5.58 days to cover

FINRA reported short interest of 561,338 shares in MDRX as of the September 15, 2026 settlement, a 0.9% increase from the prior period — about 5.6 days to cover at its recent average daily volume. On October 2, 2026, 5.7% of MDRX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)561,338 shares as of September 15, 2026
Change vs prior period▲ 0.9%
Days to cover5.58 at avg daily volume of 100,649
Daily short volume (FINRA facilities)5.7% of 26,141 shares on October 2, 2026

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with M →

No longer listed

MDRX (Veradigm Inc.) is no longer listed on a major US exchange, so Wiseek no longer shows market data for this symbol. It last appeared on NASDAQ. The filings and coverage below remain available as an archive.

feed MDRX - Latest Insights

MDRX
May 26, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
8
MDRX
Feb 17, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
8
MDRX
Feb 02, 2026, 4:23 PM EST
Filing Type: 8-K
Importance Score:
7
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets